For patients infected with hepatitis C virus who do not respond to direct-acting antiviral agents, results of a new study could mean a much brighter future.
The current study was one of the largest analyses to date of black participants receiving all-oral DAA treatment.
HCV screening of baby boomers seen in a suburban emergency department found remarkably high seropositivity rates, say authors of a new study.
Black and Hispanic boomers had lower odds of HCV screening between 2013-2015, as did female and older members of the 1945-1965 cohort.
The recently-approved HCV treatment produced SVR rates of 95% or greater and discontinuation rates for AEs were extremely low.
A new study finds cases of acute HCV infection increasing on pace with the rise in numbers of opioid abusers who inject drugs.
Favorable results seen with sofosbuvir-containing regimens in these complex patients need to be tempered with the high potential for adverse drug interactions.
A community health model based on direct treatment via primary care epxanded detection and treatment of HCV and also increased life expectancy.
Read a concise review of a new real-world study that shows high efficacy for this all-oral combination against HCV GT2.
Highlights of 3 studies from 2017 that support the role of PCPs in HCV infection treatment, including prescribing direct-acting antiviral agents.